Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
2022 · Journal of Hematology & Oncology · 159 citations
https://doi.org/10.1186/s13045-022-01382-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
0
Citations
0
h-index
0
i10-index
Haiping Liu is an academic researcher from 117th Hospital of People's Liberation Army. The author has contributed to research in topics: Polysaccharides and Plant Cell Walls & Metabolism and Genetic Disorders & Genomics and Rare Diseases.
ORCID: 0009-0005-4037-4335https://doi.org/10.1186/s13045-022-01382-5
https://doi.org/10.1016/j.jmat.2020.05.010
https://doi.org/10.1016/j.isci.2020.101497
Click to start Chat